Patents Assigned to Roche Diabetes Care, Inc.
  • Patent number: 11363991
    Abstract: A computer-implemented method and a system for analyzing glucose monitoring data indicative of a glucose level, comprising: presenting by a data processing device provided a graphical window on a display device wherein the graphical window comprises a time abscissa axis that defines time units, and a glucose ordinate axis that defines glucose units; receiving a plurality of glucose monitoring values associated with a monitoring time period by the data processing device; segmenting the plurality of glucose monitoring values into a plurality of glucose monitoring traces indicative of the glucose level; defining a reference trace segment; determining the reference trace segment for each of the plurality of glucose monitoring traces; and plotting, for a time window comprising the reference trace segment, the plurality of glucose monitoring traces within the graphical window. Furthermore, a non-transitory computer readable medium is disclosed.
    Type: Grant
    Filed: February 28, 2017
    Date of Patent: June 21, 2022
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Matthias Koehler, Bernd Steiger, Timm Wiedemann
  • Patent number: 11350822
    Abstract: Embodiments related to a system and method managing the implementation, execution, data collection, data analysis and status reporting of a structured collection procedure running on a portable, hand-held collection device are disclosed. The collection device performing the structured collection procedure has program instructions that when executed by a processor cause the processor to initiate automatically a schedule of events of the structured collection procedure upon one or more entry criteria being met at some unknown time, store in memory patient data collected in accordance to the schedule of events, end automatically the structured collection procedure upon one or more exit criteria being met at some unknown time. Status reporting can be provided throughout the execution of the collection procedure.
    Type: Grant
    Filed: August 13, 2019
    Date of Patent: June 7, 2022
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Abhishek S. Soni, Paul J. Galley, Alan Greenburg, Steven Bousamra, Stefan Weinert, Erica Diebold
  • Patent number: 11350821
    Abstract: An ambulatory medical device and a method of communication between medical devices are disclosed. In one embodiment, the medical device includes a module for communication with at least a second medical device wherein the module for communication is adapted to be activated by a value of a physiological parameter of an animal. In one embodiment, the method of the present invention involves a first medical device and at least a second medical device wherein the communication between said medical devices is activated by a value of a physiological parameter of an animal.
    Type: Grant
    Filed: August 1, 2007
    Date of Patent: June 7, 2022
    Assignee: ROCHE DIABETES CARE, INC.
    Inventors: Matthias Essenpreis, Ulrich Haueter, Nicole Bernini, Sybille Fankhauser, Sebastiaan La Bastide, Gunnar Meyer Olden, Michael Schoemaker, Kelly Heaton, Joel Jeckelmann
  • Patent number: 11346852
    Abstract: This disclosure concerns a method and a system for quality evaluation of a handheld analytical device, wherein the device is operable by a human user in a sequence of handling steps to test an analyte in a sample fluid applied on a test element, the method comprising the steps of (a) programming a handling cycle for a robot having at least one robot arm in order to mimic the sequence of handling steps, (b) operating the device in at least one handling cycle by means of the robot, (c) monitoring the operation in step (b) by a control unit to evaluate at least one parameter influencing the quality of the device.
    Type: Grant
    Filed: May 5, 2020
    Date of Patent: May 31, 2022
    Assignee: Roche Diabetes Care, Inc.
    Inventor: Wolfgang Schwoebel
  • Patent number: 11337891
    Abstract: The invention concerns a reservoir (1) for storing a liquid medicament. The reservoir (1) comprises a flexible container (10) which includes one folding layer (12), wherein the folding layer (12) includes a seam (13) which provides for a sealing of the flexible container (1). The reservoir comprises a rigid part (20) which is connected to the flexible container (10) and which includes a support (25) extending into the flexible container (10) and which includes one or more ports (21, 22) providing fluidic access to the flexible container (10). The reservoir comprises a porous hydrophilic membrane (26) which is connected to the support (25) of the rigid part (20). The invention further concerns a method for producing of a reservoir (1).
    Type: Grant
    Filed: November 21, 2017
    Date of Patent: May 24, 2022
    Assignee: ROCHE DIABETES CARE, INC.
    Inventors: Wilhelm Leichner, Hans List
  • Patent number: 11342056
    Abstract: A method for characteristic monitoring in conjunction with a mode of continuously measured blood glucose values, in a monitor apparatus provided with a processor, a memory, a data interface, an input device, and a signaling device, the method comprising: providing a first set of event specific characteristics assigned to a first event, the first set of event specific characteristics being different from a second set of event specific characteristics assigned to a second event which is different from the first event, receiving blood glucose value data performing a safety check by comparing the first set of event specific characteristics to present characteristics derived from the blood glucose value data and/or the characteristic values, generating a warning signal or generating a safety signal, and outputting an output signal. A monitor apparatus is also disclosed.
    Type: Grant
    Filed: December 11, 2015
    Date of Patent: May 24, 2022
    Assignee: Roche Diabetes Care Inc.
    Inventors: Bernd Steiger, Juergen Rasch-Menges
  • Patent number: 11327931
    Abstract: A structured testing method for diagnostic or therapy support of a patient with a chronic disease and devices thereof are disclosed which implement a structured collection procedure based on a medical use case and/or question which provides at least one or more parameters defining entry criterion, a schedule of events, adherence criterion, and exit criterion. The entry criterion establish conditions needed to be met prior to obtaining biomarker data from the patient. Each event can include one or more of a performance time, patient guidance to perform the event, a request for information from the patient a request for patient action, and a request for collection of biomarker data from the patient. The adherence criterion can be used to assess whether an event performed is acceptable to addressing the medical use case and/or question, and the exit criterion establishes conditions needed to be met prior to exiting the collection procedure.
    Type: Grant
    Filed: January 7, 2020
    Date of Patent: May 10, 2022
    Assignee: Roche Diabetes Care, Inc.
    Inventors: P. Douglas Walling, Juergen Rasch-Menges, Stefan Weinert, Steven Bousamra, Abhishek S. Soni, Christoph Eisenhardt
  • Patent number: 11324883
    Abstract: Disclosed is a method for initializing an ambulatory infusion system. The method includes providing a liquid drug cartridge including a cartridge body, and a cartridge piston. The method further includes providing a dosing unit including a metering pump unit with a dosing cylinder and a dosing piston. The dosing unit further includes a valve unit configured for switching between a filling state and a draining state. The filling port being fluidically coupled with the dosing cylinder in the filling state and the draining port is fluidically coupled with the dosing cylinder in the draining state. The method further includes a) exerting an initialization force displacing the cartridge piston, and b) increasing a fluidic volume of the dosing cylinder by displacing the dosing piston, thereby sucking liquid out of the liquid drug cartridge into the dosing cylinder and further displacing the cartridge piston, without the initialization pushing force being exerted.
    Type: Grant
    Filed: December 13, 2017
    Date of Patent: May 10, 2022
    Assignee: ROCHE DIABETES CARE, INC.
    Inventor: Hans List
  • Patent number: 11324563
    Abstract: Protective coverings are provided for hand-held medical devices that have a measuring port for a disposable analytical test element. The coverings also include a sleeve having a reception opening and can be slipped over the devices to at least partially enclose the devices in a usable protected state. The coverings further include a test element adapter formed as an integral part of the sleeve to receive the test element in alignment with a measuring port, where the sleeve includes the test element adapter and is arranged as a sealing barrier between the test element and the device port in a protected state.
    Type: Grant
    Filed: October 1, 2015
    Date of Patent: May 10, 2022
    Assignee: ROCHE DIABETES CARE, INC.
    Inventors: Herbert Harttig, Sebastian Liedtke, Matthias Mock
  • Patent number: 11324663
    Abstract: The invention concerns a method and an apparatus for transferring an amount of a liquid drug (11) from a supply container (1) having stored the liquid drug (11) to a collapsible reservoir (2), the method including and the apparatus enabling the steps of: a) providing a fluid connection (3) between the supply container (1) and the collapsible reservoir (2); b) subjecting the liquid drug (11) stored in the supply container (1) to an environmental pressure; c) subjecting the collapsible reservoir (2) to a positive pressure relative to the environmental pressure, thereby collapsing the collapsible reservoir (2) and transferring gas comprised in the collapsible reservoir (2) from the collapsible reservoir (2) to the supply container (1); d) subjecting the collapsible reservoir (2) to a negative pressure relative to the environmental pressure, thereby expanding the collapsible reservoir (2) and transferring the amount of the liquid drug (11) from the supply container (1) to the collapsible reservoir (2).
    Type: Grant
    Filed: November 20, 2017
    Date of Patent: May 10, 2022
    Assignee: ROCHE DIABETES CARE, INC.
    Inventor: Frank Deck
  • Patent number: 11318493
    Abstract: A slot die shim for use with a slot die, the slot die shim including a first channel configured to receive a first coating, a second channel configured to receive a second coating, and a third channel configured to receive a third coating. The slot die shim simultaneously dispenses the first coating through the first channel, the second coating through the second channel, and the third coating through the third channel onto a substrate. The coatings can be applied at different flow rates and include different test reagents. A vacuum force is applied to the first, second, and third coatings to control a width and a thickness of each of the coatings and a gap or distance between the coatings. The first, second, and third coatings are placed near one another or directly in contact with one another to minimize the area required for the coatings.
    Type: Grant
    Filed: April 10, 2018
    Date of Patent: May 3, 2022
    Assignee: ROCHE DIABETES CARE, INC.
    Inventors: Harvey B. Buck, Jr., Randall K. Riggles, Thomas D. Hahn, Mike Limbaugh, Timothy Owens
  • Patent number: 11303510
    Abstract: The disclosure relates to a method and a system for a wireless data communication between a sensor system and a receiver capable of receiving analyte values sensed by the sensor system in a continuous analyte monitoring. The method includes establishing an unconnected mode operation for the system. The receiver receives a first data package broadcasted by the sensor system that has first status data indicative of a device status and/or an analyte value status. The first status data is processed by a receiver controller. A connected mode operation is established for the system responsive to determining at least one of a critical device status and a critical analyte value status. The establishing includes establishing a communication channel between the sensor system and the receiver and receiving a second data package transmitted by the sensor system in the receiver, the second data package comprising one or more analyte values.
    Type: Grant
    Filed: December 21, 2018
    Date of Patent: April 12, 2022
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Carsten Mueglitz, Felix Bootz
  • Publication number: 20220105261
    Abstract: Embodiments of the present invention are directed to devices, systems and methods for delivering therapeutic fluid (e.g., insulin) into the body, including a skin adherable cradle, for retaining a therapeutic fluid dispenser for delivering a therapeutic fluid to a user.
    Type: Application
    Filed: October 13, 2021
    Publication date: April 7, 2022
    Applicant: Roche Diabetes Care, Inc.
    Inventors: Ofer Yodfat, Gavriel J. Iddan, Avraham Neta
  • Patent number: 11294407
    Abstract: A device and method of providing instruction to a patient regarding the dosing of insulin is provided.
    Type: Grant
    Filed: May 20, 2019
    Date of Patent: April 5, 2022
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Maury Zivitz, Lois Jovanovic
  • Publication number: 20220098636
    Abstract: Detection reagents, multi-analyte test elements, test systems, and multi-analyte measuring methods are provided. In particular, multi-analyte test elements have (1) a first working electrode and first counter electrode pair covered with a first analyte-specific reagent that includes an enzyme, a coenzyme and a first mediator and have (2) a second working electrode covered with a second analyte-specific reagent that includes an enzyme, a coenzyme and a second mediator, where the second mediator is different than the first mediator. The single counter electrode can be used as the counter electrode for both the first and second analyte measurements at their respective working electrodes. Moreover, the mediator concentrations, measurement ranges, and applied potential differences are not the same for each analyte-specific measurement.
    Type: Application
    Filed: December 10, 2021
    Publication date: March 31, 2022
    Applicant: Roche Diabetes Care, Inc.
    Inventors: Harvey Buck, Terry A. Beaty, Stacy Hunt DuVall
  • Publication number: 20220101973
    Abstract: The present invention relates to a computer-implemented method for aiding in the guidance of diabetes drug therapy of an individual suffering from diabetes mellitus. The method is based on glucose data from said individual that are received at a processing unit, wherein said glucose data comprise at least three fasting glucose measurement values from said individual, and/or at least three matched pre-prandial glucose measurement values and postprandial glucose measurement values at the same meal from said individual. Further contemplated by the present invention is a device for aiding in the guidance of drug diabetes therapy of an individual suffering from diabetes, said device comprising a processing unit, and a computer program including computer-executable instructions, wherein said instructions, when executed by the processing unit, causes the processing unit to perform the computer-implemented method of the present invention.
    Type: Application
    Filed: October 8, 2019
    Publication date: March 31, 2022
    Applicant: Roche Diabetes Care, Inc.
    Inventors: Joerg Weissmann, Elena Acmet, Francesco Giorgino
  • Patent number: 11284815
    Abstract: A diabetes management system includes a handheld medical device, a mobile computing device, and a diabetes management application. The handheld medical device is configured to measure glucose in a sample of fluid residing in a test strip and associate a measurement time with the glucose measurement. The diabetes management application is configured to request a current device time from the RTC, determine a first device delta time by determining a difference between the current device time and an internal clock time, and associate a first timestamp with a glucose measurement, wherein the first timestamp is equal to the measurement time plus the first device delta time.
    Type: Grant
    Filed: April 2, 2014
    Date of Patent: March 29, 2022
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Eric S. Carlsgaard, Paul J. Galley, Mark G. Mears, Benoit P. Menez, Hemlata Nayee, Jose Salazar-Galindo
  • Patent number: 11284817
    Abstract: Disclosed is a method of using a handheld meter configured for determining an analyte concentration in a body fluid. In the inventive method, a handheld meter with a disposable test element is provided and the test element is positioned at an application site of the meter. A body fluid from a user's body part is applied to a reaction area of the test element and a series of measurement values from the reaction area of the test element is detected. A proximity sensor senses the presence of the body part in a monitored space in proximity to the reaction area of the test element. The measured values are processed as a function of an output signal of the proximity sensor. Consequently, bias in the determination of the analyte concentration caused by the presence of the body portion is reduced or eliminated. An associated handheld meter is also disclosed.
    Type: Grant
    Filed: April 11, 2019
    Date of Patent: March 29, 2022
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Volker Huellen, Max Berg
  • Publication number: 20220087582
    Abstract: A test strip eject mechanism for a fluid testing device comprising an actuation button and a lever having a distal end movably engaged with the button, the lever configured to rotate about a fulcrum, wherein the lever has a proximal end movably engaged with a sled which slides to transport the test strip, the device configured such that a user's insertion of a test strip onto the sled and in an insertion direction into the device causes the sled to contact the lever arm and the lever arm to contact and move the actuation button in an outward direction of the medical device and into a position where the actuation button can be actuated by the user.
    Type: Application
    Filed: September 24, 2020
    Publication date: March 24, 2022
    Applicant: Roche Diabetes Care, Inc.
    Inventors: Michel Alain Jean Marie Cadio, Ahmet Konya
  • Patent number: D951281
    Type: Grant
    Filed: August 2, 2021
    Date of Patent: May 10, 2022
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Matthias Koehler, Nils Babion, Gabriele Schoepfer, Lara Valenti, Clinton Young